Guaranteed Income and Financial Treatment
Running, not enrolling · Not applicable
Conditions studied: Cancer, Financial Hardship, Quality of Life
In brief
The goal of this clinical trial is to learn if providing advanced cancer patients with $1000/month for 12 months will improve cancer outcomes. The main questions it aims to answer are: To what extent does receiving $1000/month additional income reduce financial hardship? To what extent does receiving $1000/month additional income improve quality of life? Does receiving $1000/month additional income improve survival outcomes? Participants will: Receive $1000/month for 12 months Complete a survey every 3 months for 12 months If selected, participate in semi-structured interviews about their financial behaviors
Key facts
- Study ID
- NCT06611982
- Run by
- Meredith Doherty, PhD, LCSW
- People needed
- 250
- Starts
- 2023-04-01
- Expected to finish
- 2026-07-30
- Last updated by the study team
- 2026-03-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age = 18 or older
- Newly diagnosed or recurrent advanced cancer (Stage 3 or 4)
- Receiving chemotherapy or immunotherapy (with or without radiation) at one of the recruitment sites
- Within 12 months of receiving systemic therapy and on surveillance at one of the recruitment sites
- ECOG performance status of 1 - 2
- A Pennsylvania Medicaid beneficiary
- A Pennsylvania resident
You may not qualify if…
- Eligible for hospice (i.e. determined by provider to have a prognosis of 6 months or less) at time of randomization
- Unable to communicate in English, Spanish, or Mandarin
Where it is running
- Pennsylvania Hospital — Philadelphia, New York, United States
- Penn Presbyterian Medical Center — Philadelphia, Pennsylvania, United States
- Jefferson Health — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.